Part Two: Habit and Customs, Obesity and Parkinson's Disease
Muslimat Kehinde Adebisi, Li Xuezhong, Ehianeta Teddy and Liuyi
Article Type: Review Article | First Published: October 21, 2019
Keyword used in searching for similar articles on PubMed were, Obesity, hyperlipidemia, Metabolic syndrome (MetS), Neurodegenerative disorders, Parkinson’s diseases (PD). Papers from 2014-2019 related were compiled. Cases at Zhenjiang First people’s hospital similar was compiled to draw conclusions. I evaluated the association between years of diagnosis (YOD) of PD and BMI for both male and female patients and compared to controlled groups. There was a statistically significance between YOD ...
Obesity may Increase the Prevalence of Parkinson’s Disease while Parkinson's may Reduce Obesity Index in Patients
Muslimat Kehinde Adebisi, Ehianeta Teddy, Mzee Said Abdulraman Salim, Liuyi, Abdul Nazif Mahmud, Aaron Gia Kanton and Abdullateef Taiye Mustapha
Article Type: Research Article | First Published: October 14, 2019
Currently Parkinson's disease is becoming more common among younger people of ages from 30-40 years. The incidence is higher among patients with higher BMI, some reports has it that Obesity is a risk factor for Parkinson’s disease while some reported that there is no relationship between obesity and Parkinson’s disease. Parkinson’s disease patient at the time of diagnosis has a above normal BMI but this goes below normal as the disease progresses. Therefore, it is important to explore the ...
A Clinicopathologic Case Report of a Female with Valosin-Containing Protein (VCP) Gene Mutation Related Disease
Abhilasha Surampalli, Angele Nalbandian, Sandra Donkervoort, Manaswitha Khare, Annabel Wang, Rudolph Castellani, Hong Yin, Ana Rubio, Payal Patel, John Weiss, Tahseen Mozaffar and Virginia E Kimonis
Article Type: Case Report | First Published: December 19, 2018
Valosin Containing Protein (VCP) gene mutations have been reported in ~1-2% of familial amyotrophic lateral sclerosis (ALS). We report a case of clinically defined and neuropathologically confirmed ALS in a 48-year-old, emaciated female with a p.R155C (c.463 C > T) mutation in VCP gene. She presented with progressive generalized muscular weakness, weight loss, dyspnea on exertion, combined nasal and spastic dysarthria, positive jaw jerk and exaggerated gag reflex. Electrodiagnostic studies revea...
Rare and Hereditary Causes of Stroke-A Literature Review
Eyisi CS, Onwuekwe IO, Eyisi IG and Ekenze O
Article Type: Research Article | First Published: November 19, 2018
A stroke is a Focal (or global) neurological impairment of sudden onset, lasting more than 24 hrs and usually from a vascular cause. Clinical presentation span through a myriad of motor deficits, sensory deficits, seizures, personality/behavioral anomalies, dementia, brainstem stroke syndromes and herniation syndromes. Traditionally stokes are classified as ischemic or hemorrhagic, the former more common than the latter in a ratio of 6:1. Conventional risk factors for stroke occurrence have al...
Multiple Episodes of Full-Body Tremors: An Unexpected Adverse Effect during an Alzheimer's Disease Investigational Drug Study
Jeffrey T Apter, Ivy A Billones and Kaylee White
Article Type: Case Report | First Published: November 16, 2018
A 69-year-old Caucasian female experienced multiple episodes of full-body tremors during the extension phase of the clinical study. The investigational drug was taken in the mornings. The patient reported that the AE started six months prior with episodes occurring 1-2 times per week eventually escalating almost daily and was more apparent during midnight hours and upon waking up. Further review of previous progress notes states that the patient denied the AE and even stated full compliance and ...
Apolipoprotein E Fragmentation within Lewy Bodies of the Human Parkinson's Disease Brain
Troy T Rohn and Jacob M Mack
Article Type: Research Article | First Published: February 23, 2018
Although harboring the Apolipoprotein E4 (APOE4) allele is a well-known risk factor in Alzheimer's disease (AD), whether a similar risk holds true for Parkinson's disease (PD) is currently not known. To investigate whether apoE pathology is present in PD, an immunohistochemical study was undertaken with fixed, human PD brain sections from the substantia nigra utilizing a recently characterized antibody that detects an amino-terminal fragment of apoE. This antibody, termed the apoE cleavage fragm...